Clinical Trial: InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Type 1 Diabetes Mellitus
Study Type: INTERVENTIONAL
Official Title: Feasibility of a Bolus Calculator Without Carbohydrate Counting in Type 1 Diabetes Patients Under Multiple Daily Injections (MDI) Therapy: A Supervised Randomized Controlled Trial.
Brief Summary:
This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention.In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.
Read more